|
|
|
|
|
|
By Matthew Pillar, Editor, Bioprocess Online
| You’ve heard San Francisco was buzzing with cautious optimism last month. You’ve seen the M&A activity that’s buoying spirits and you know inflation and interest rates are stabilizing, if not improving. You may not have considered these three trendlines, offered by a guy who spent his time at JPM doing more listening than anything. |
|
|
|
By Maik W. Jornitz, principal consultant, BioProcess Resources LLC. | Biopharmaceutical companies calling their facilities "state-of-the-art" should use the latest, most cutting-edge technologies and techniques. Many say they meet that standard — but do they really? |
|
|
|
|
|
|
| Advancing ATMP Fluid Management | e-book | Single Use Support | In this e-book we explore what ATMPs are, what they can achieve, ATMP fluid management, and ATMP manufacturing challenges, as well as receiving expert answers to common questions. |
|
|
| Best Practices For Multiuse Bioreactor Sterilization | Application Note | Getinge | Review the results of studies into the optimal method for cleaning and sterilizing a multiuse bioreactor, headplate, tubing, vent filters, liquid media, and filled liquid addition bottle. |
|
|
| USP <382>- Packaging/Delivery System Integrity | Article | West Pharmaceutical Services, Inc. | Review the scope and testing procedures required by General Chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems. |
|
|
|
| A Globally Unique Capability For Nanoforming HPAPIs | Article | By Dr. David Rowe and Antonio da Silva, Nanoform | As demand for high-potency active pharmaceutical ingredients (HPAPIs) rises, ensuring your company utilizes specialized facilities with HPAPI handling capabilities is crucial. |
|
|
|
|
|
|
| Sterile Filtration And Quality Risk Management | White Paper | Cytiva | Process control is essential for manufacturing sterile products. Explore the role of filtration for bioburden control in quality risk management and contamination control strategies. |
|
|
| Developing Robust mRNA Processes In A cGMP Environment | Poster | By Clemens Jakobi, Michal DomaĆski, and Telmo Graça, Lonza | Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Webinar: Accelerating Rare Disease Treatments From Concept To Cure | The swift progression from gene discovery to mass vaccination in the development of COVID-19 vaccines has set a remarkable precedent. This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey. Click here to learn more. |
|
|
Connect With Bioprocess Online: |
|
|
|